Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases

摘要

The present invention relates to a combination of a selective PDB4 inhibitor and an anticholinergic agent for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease, with the proviso that the anticholinergic agent is not a tiotropium salt.